Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Sen. Richard Blumenthal (D-Conn.) sent a letter to the Department of Justice Monday, urging the entity to reject a recent settlement with Canonsburg, Pa.-based drugmaker Mylan.
TPC — a network of independent healthcare providers and regional purchasing coalition based in Plano, Texas — will partner with Resource Optimization & Innovation, a provider-owned group purchasing organization based in St. Louis.
When searching for savings opportunities, it is wise to sort your item master file using the Pareto principle, also known as the 80/20 rule, says John Mateka, MBA, MHA, interim director of materials management for Florence, S.C.-based McLeod Health.
New York City-based Pfizer will start shipping its biosimilar copy of Johnson & Johnson's best-selling arthritis drug Remicade in November, offering the drug at a 15 percent discount, according to Reuters.
Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to Japan-based Terumo for about $1.1 billion, reports Reuters.
In a recent press release, TPC, a network of independent healthcare providers and regional purchasing coalition across Arkansas, Missouri and Texas, announced they signed an agreement with Resource Optimization & Innovation (ROi), a provider-owned supply chain organization, for access to…
Staff
The number of Medicare beneficiaries receiving durable medical equipment items decreased after the implementation of a competitive bidding program, possibly from a reduction in device fraud, according to a recent report from the U.S. Government Accountability Office.
Wayne, Pa.-based device maker Teleflex earned Food and Drug Administration approval for its Arrow Midline catheter.
The Food and Drug Administration recently approved the use of a prefilled syringe as an acceptable delivery method for the drug Lucentis.
Ariad Pharmaceutical investors lost $387 million Friday following a tweet from Sen. Bernie Sanders' (I-Vt.) twitter account that called out the drug company for its high prices in front of an audience of 2.6 million followers, reported The Next Web.